Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Korsana Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −16 vs. Q1 2023
- Shares held
- 996.0K
- −35.6K (−3.5%) vs. Q1 2023Converted for a 1-for-20 split
- Total value
- $4.10M
- −$4.85M (−54.2%) vs. Q1 2023
- New holders
- 2
- 3 more added
- Sold out
- 18
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $11.2M |
| Q1 2026 | 17 | $249.0K |
| Q4 2025 | 19 | $376.3K |
| Q3 2025 | 17 | $595.4K |
| Q2 2025 | 17 | $1.06M |
| Q1 2025 | 18 | $931.7K |
| Q4 2024 | 19 | $1.23M |
| Q3 2024 | 15 | $2.70M |
| Q2 2024 | 17 | $2.41M |
| Q1 2024 | 15 | $3.42M |
| Q4 2023 | 15 | $3.58M |
| Q3 2023 | 17 | $3.66M |
| Q2 2023 | 18 | $4.10M |
| Q1 2023 | 34 | $8.95M |
| Q4 2022 | 40 | $13.7M |
| Q3 2022 | 38 | $18.3M |
| Q2 2022 | 41 | $11.5M |
| Q1 2022 | 50 | $25.6M |
| Q4 2021 | 56 | $40.7M |
| Q3 2021 | 62 | $75.8M |
| Q2 2021 | 68 | $96.0M |
| Q1 2021 | 71 | $62.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Korsana Biosciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Slate Path Capital LP | 357,880 | $1.47M | 0.05% | 00.0% | UnchangedConverted for a 1-for-20 split |
| MFN Partners Management, LP | 169,460 | $696.5K | 0.02% | 00.0% | UnchangedConverted for a 1-for-20 split |
| FMR LLC | 164,949 | $677.9K | 0.00% | −4,569−2.7% | ReducedConverted for a 1-for-20 split |
| Artal Group S.A. | 138,955 | $572.0K | 0.02% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Vanguard Group Inc | 81,169 | $334.4K | 0.00% | −1,408−1.7% | ReducedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 29,722 | $122.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BlackRock Inc. | 18,000 | $74.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Captrust Financial Advisors | 14,631 | $60.3K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Jane Street Group, LLC | 13,364 | $55.1K | 0.00% | +13,364 | New |
| Acadian Asset Management LLC | 5,437 | $22.0K | 0.00% | −6,161−53.1% | ReducedConverted for a 1-for-20 split |
| Morgan Stanley | 823 | $3.39K | 0.00% | +221+36.7% | AddedConverted for a 1-for-20 split |
| Royal Bank of Canada | 839 | $3.00K | 0.00% | +838+111,766.7% | AddedConverted for a 1-for-20 split |
| Group One Trading, L.P. | 540 | $2.22K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| UBS Group AG | 186 | $766 | 0.00% | −526−73.9% | ReducedConverted for a 1-for-20 split |
| Rhumbline Advisers | 22 | $94 | 0.00% | +22 | New |
| Wells Fargo & Company | 14 | $58 | 0.00% | +0+3.3% | AddedConverted for a 1-for-20 split |
| Northwestern Mutual Wealth Management Co | 1 | $4 | 0.00% | −35−97.2% | ReducedConverted for a 1-for-20 split |
| CWM, LLC | 14 | $0 | 0.00% | −1−5.7% | ReducedConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −5,771−100.0% | Sold outConverted for a 1-for-20 split |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −5,750−100.0% | Sold outConverted for a 1-for-20 split |
| Colony Group LLC | 0 | $0 | 0.00% | −5,144−100.0% | Sold outConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −4,335−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,040−100.0% | Sold outConverted for a 1-for-20 split |
| Franklin Resources Inc | 0 | $0 | 0.00% | −3,946−100.0% | Sold outConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,259−100.0% | Sold outConverted for a 1-for-20 split |
| Intrinsic Value Partners, LLC | 0 | $0 | 0.00% | −2,155−100.0% | Sold outConverted for a 1-for-20 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,887−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −900−100.0% | Sold outConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −664−100.0% | Sold outConverted for a 1-for-20 split |
| Penobscot Investment Management Company, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-20 split |
| Clean Yield Group | 0 | $0 | 0.00% | −6−100.0% | Sold outConverted for a 1-for-20 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-20 split |
| MV Capital Management, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-20 split |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-20 split |
| Concord Wealth Partners | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-20 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold outConverted for a 1-for-20 split |